Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study
暂无分享,去创建一个
E. J. Hwang | J. Yim | Sung A. Kim | S. Choi | Jinwoo Lee | Chang-Hoon Lee | Hye-Rin Kang | N. Kwak
[1] J. Brożek,et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] J. Yim,et al. BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease. , 2020, American journal of respiratory and critical care medicine.
[3] J. Brożek,et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline , 2020, European Respiratory Journal.
[4] J. Yim,et al. Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study , 2020, BMC Pulmonary Medicine.
[5] H. Kida,et al. Characteristic chest CT findings for progressive cavities in Mycobacterium avium complex pulmonary disease: a retrospective cohort study , 2020, Respiratory Research.
[6] K. Carriere,et al. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study , 2019, European Respiratory Journal.
[7] C. Ki,et al. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease. , 2019, Respiratory medicine.
[8] T. Shim,et al. Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization , 2019, PLoS medicine.
[9] T. Shim,et al. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease. , 2019, Respiratory medicine.
[10] W. Koh,et al. Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007–2016 , 2019, Emerging infectious diseases.
[11] S. Cooray,et al. Global Epidemiology of NTM Disease (Except Northern America) , 2018, Nontuberculous Mycobacterial Disease.
[12] T. Franquet,et al. Cavitary Lung Diseases: A Clinical‐Radiologic Algorithmic Approach , 2018, Chest.
[13] S. Holland,et al. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement , 2018, European Respiratory Journal.
[14] C. Haworth,et al. British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) , 2017, BMJ Open Respiratory Research.
[15] C. Ki,et al. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype , 2017, European Respiratory Journal.
[16] Mi Young Kim,et al. Comparison of chest CT findings in nontuberculous mycobacterial diseases vs. Mycobacterium tuberculosis lung disease in HIV-negative patients with cavities , 2017, PloS one.
[17] J. Yim,et al. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Satoshi Mitarai,et al. Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan , 2016, Emerging infectious diseases.
[19] J. Falkinham. Current Epidemiologic Trends of the Nontuberculous Mycobacteria (NTM) , 2016, Current Environmental Health Reports.
[20] M. Tashiro,et al. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. , 2016, Medical mycology.
[21] K. Winthrop,et al. Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012. , 2015, Annals of the American Thoracic Society.
[22] O. Kwon,et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. , 2013, Medical mycology.
[23] K. Lee,et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. , 2013, Annals of the American Thoracic Society.
[24] T. Kanauchi,et al. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. , 2012, American journal of respiratory and critical care medicine.
[25] D. Raoult,et al. rpoB sequence-based identification of Mycobacterium avium complex species. , 2008, Microbiology.
[26] K. Chida,et al. Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings , 2008, European Respiratory Journal.
[27] J. Stout,et al. Cavitary Pulmonary Disease , 2008, Clinical Microbiology Reviews.
[28] N. Müller,et al. Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.
[29] N. Pace,et al. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline , 2008 .
[30] Robert Horsburgh,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.
[31] M. Chung,et al. Hypothesis on the evolution of cavitary lesions in nontuberculous mycobacterial pulmonary infection: thin-section CT and histopathologic correlation. , 2005, AJR. American journal of roentgenology.
[32] Yoon-Hoh Kook,et al. Identification of Mycobacterial Species by Comparative Sequence Analysis of the RNA Polymerase Gene (rpoB) , 1999, Journal of Clinical Microbiology.